Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1058471

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1058471

Canada - Healthcare, Regulatory and Reimbursement Landscape

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1995
PDF (Site License)
USD 2992
PDF (Global License)
USD 3990

Add to Cart

GlobalData, the industry analysis specialist, has released its latest report: "Canada - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The growth in Canada's pharmaceutical market is attributed to the adoption of R&D activities towards advanced therapies and increased partnerships among pharmaceutical companies and academia, small and medium-sized enterprises (SMEs), government, and research centers. In 2020, the Canadian pharmaceutical market was the ninth largest globally in terms of value. Canada's pharmaceutical market, based on production value, $23.86 billion in 2013 increased to $25.55 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 0.98%. It is forecast to reach about $27.08 billion in 2026. In 2016, the medical devices market in Canada was worth $8.02 billion, which increased at a CAGR of 6.09% to $10.79 billion in 2021. It is expected to grow at a CAGR of 3.96% from 2022 to reach $12.96 billion in 2027.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Abbvie, Ceapro, and Thera technologies.
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Boston Scientific, Bausch Health, and AlphaProTech.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Canadian healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Canadian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canadian healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Product Code: GDHC0023CHR

Table of Contents

1. Table of Contents

  • 1.1 List of Figures
  • 1.2 List of Tables

2. Executive Summary

  • 2.1 Executive Summary
  • 2.2 Key Highlights - Facts about the Canadian Healthcare Market
  • 2.3 Key Highlights: Healthcare Startups in Canada
  • 2.4 Key Events: Canadian Healthcare Timeline, 2015-2021
  • 2.5 Key Events: Canadian Pharmaceutical Market
  • 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
  • 2.7 Key Events: Top Completed Deals by Value, 2020-2021
  • 2.8 Country Profile, Canada, 2020

3. Overview of Pharmaceutical Market

  • 3.1 Pharmaceutical Market - Overview
  • 3.2 Pharmaceutical Market - Exports
  • 3.3 Pharmaceutical Market - Imports
  • 3.4 Pharmaceutical Market - Supply Channels, Canada
  • 3.5 Pharmaceutical Market - Market Segments
  • 3.6 Pharmaceutical Market - Market Segment, Generics, Canada
  • 3.7 Pharmaceutical Market - Market Segment, Biologics and Biosimilars, Canada
  • 3.8 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Canada
  • 3.9 Major Therapeutic Areas, Canada
  • 3.10 COVID-19 Epidemiology, Canada
  • 3.11 COVID-19 Impact and Developments in the Healthcare Market, Canada
  • 3.12 Covid-19 Clinical Trials Landscape, Canada
  • 3.13 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

  • 4.1 Medical Device Market - Overview
  • 4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

  • 5.1 Drivers
  • 5.2 Barriers

6. Deal Analysis

  • 6.1 Deal Analysis: Pharmaceutical Market, Canada, 2020-2021
  • 6.2 Deal Analysis: Medical Device Market, Canada, 2020-2021

7. HealthTech Landscape

  • 7.1 HealthTech Landscape, Canada
  • 7.2 HealthTech Deals Landscape, Canada
  • 7.3 Key HealthTech Deals, Canada
  • 7.4 Adoption of Technology in Healthcare, Canada
  • 7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Canada
  • 7.6 HealthTech Landscape: Benefits and Risks, Canada

8. Market Access

  • 8.1 Overview of Healthcare System, Canada
  • 8.2 Reimbursement of Pharmaceutical Products, Canada
  • 8.3 Reimbursement of Medical Devices, Canada
  • 8.4 Overview of Insurance Providers, Public Insurance, Canada
  • 8.5 Overview of Insurance Providers, Private Insurance, Canada
  • 8.6 Healthcare Spending and Prescription Drug Price Trend, Canada
  • 8.7 Pricing Policies, Canada
  • 8.8 Regulatory Landscape, Canada
    • 8.8.1 Marketing Authorization for Pharmaceutical Products, Canada
    • 8.8.2 Marketing Authorization for Medical Devices, Canada
    • 8.8.3 Intellectual Property Rights, Patent, Canada
    • 8.8.4 Intellectual Property Rights, Trademark, Canada
    • 8.8.5 Clinical Trial Regulation Process, Canada
    • 8.8.6 Pharmaceutical Clinical Trials Landscape, Canada
    • 8.8.7 Medical Devices Clinical Trials Landscape, Canada
    • 8.8.8 Pharmaceutical Export and Import, Canada
    • 8.8.9 Pharmaceutical Advertising Regulations, Canada
    • 8.8.10 Pharmacy Regulations, Canada
    • 8.8.11 Labeling and Packaging Regulations, Canada

9. Country Healthcare Landscape

  • 9.1 Canadian Healthcare Policy Highlights
  • 9.2 Healthcare Facilities, Canada
  • 9.3 Healthcare Parameters, Canada
  • 9.4 Life Expectancy and Immunization Rate, Canada
  • 9.5 Environmental Health, Canada
  • 9.6 Healthcare Personnel, Canada
  • 9.7 Disease Burden, Canada
  • 9.8 Healthcare Expenditure, Canada

10 Trade Associations, Canada

11 Trade Fairs, Canada

12 Opportunities and Challenges

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Coverage
    • 13.1.2 Secondary Research
    • 13.1.3 Forecasts
  • 13.2 Bibliography
  • 13.3 About GlobalData
  • 13.4 Contact Us
  • 13.5 Disclaimer
Product Code: GDHC0023CHR

List of Tables

List of Tables

  • Table 1: Approved Biosimilars, Canada 2020-2021
  • Table 2: Major Therapeutic Areas by Production Value ($B), Canada, 2020
  • Table 3: COVID-19 Indicators (Number of Cases), Global and Canada, 2020-2021
  • Table 4: COVID-19-Related Travel Restrictions, Canada, 2020-2021
  • Table 5: Authorized COVID-19 Vaccines, Canada, 2020-2021
  • Table 6: List of Authorized Treatments for COVID-19, Canada, 2020-2021
  • Table 7: Total COVID-19 Vaccine Distribution Canada, 2021
  • Table 8: COVID-19 IVD Products (December '20- December '21), Canada, 2020-2021
  • Table 9: Medical Device Market, Canada, Major Segments ($B), 2021
  • Table 10: Orthopedic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
  • Table 11: General Surgery Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
  • Table 12: Hospital Supplies Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
  • Table 13: Cardiovascular Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
  • Table 14: Diabetes Care Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
  • Table 15: AI/ML Medical Devices Approved by Health Canada, Canada, 2020-2021
  • Table 16: List of Provincial Insurance Programs, Canada, 2021
  • Table 17: TPF, Pricing Tiers, Canada, 2021
  • Table 18: Fees for Examination of Drug Submission, Canada, 2021
  • Table 19: Fees for Right to Sell Drugs, Canada, 2021
  • Table 20: Classification and Regulation Regarding Medical Devices, Canada, 2021
  • Table 21: Fees for Examination of Medical Devices License Application, Canada, 2021
  • Table 22: Fees for Right to Sell Medical Devices, Canada, 2021
  • Table 23: Patent Fees, Canada, 2021
  • Table 24: Trademark Fees, Canada, 2021
  • Table 25: Importation Requirements for Health Products in Canada
  • Table 26: Trade Fairs, Canada

List of Figures

List of Figures

  • Figure 1: Pharmaceutical Market, Canada, Revenue ($B and CADB), 2013-2020
  • Figure 2: Medical Devices Market, Canada, Revenue ($B), 2016-2021
  • Figure 3: Healthcare Startups in Canada, 2021
  • Figure 4: Country Profile, Canada, 2020
  • Figure 5: Pharmaceutical Market, Canada, Revenue ($B and CADB), 2013-2020
  • Figure 6: Pharmaceutical Market, Canada, Revenue Forecast ($B and CADB), 2021-2026
  • Figure 7: Pharmaceutical Exports ($B), Canada, 2013-2020
  • Figure 8: Top Export Partners, Canada, 2020
  • Figure 9: Pharmaceutical Imports ($B), Canada, 2013-2020
  • Figure 10: Top Import Partners, Canada, 2020
  • Figure 11: Pharmaceutical Market, Supply Channel, Canada, 2021
  • Figure 12: Generic Share by Value (%), Canada, 2013-2020
  • Figure 13: Generic Share by Volume (%), Canada, 2013-2020
  • Figure 14: OTC Medicines Market, Major Distribution Channels ($B), Canada, 2020
  • Figure 15: OTC Medicines Market, Revenue ($B), Canada, 2013-2020
  • Figure 16: OTC Medicines Market, Major Categories ($M), Canada, 2020
  • Figure 17: Major Therapeutic Areas by Production Value, Canada, 2020
  • Figure 18: COVID-19 Cases, Canada, 2020-2021
  • Figure 19: COVID-19 Deaths, Canada, 2020-2021
  • Figure 20: COVID-19 Fiscal Stimulus Timeline, Canada, 2020-2021
  • Figure 21: COVID-19 Vaccine Doses Administration, Number of Vaccine Doses Administered, Canada, 2021
  • Figure 22: COVID-19 Clinical Trials Count by Market Categories, Canada, 2020-2021
  • Figure 23: COVID-19 Clinical Trials Count by Trial Status, Canada, 2020-2021
  • Figure 24: Top COVID-19 Clinical Trials Sponsors by Trial Count, Canada, 2020-2021
  • Figure 25: Medical Devices Market, Canada, Revenue ($B), 2016-2021
  • Figure 26: Medical Devices Market, Canada, Revenue Forecast ($B), 2022-2027
  • Figure 27: Medical Device Market, Canada, Major Segments (%), 2021
  • Figure 28: Orthopedic Devices Market, Canada, Revenue ($B), 2017-2025
  • Figure 29: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2020
  • Figure 30: General Surgery Market, Canada, Revenue ($B), 2017-2025
  • Figure 31: General Surgery Market, Canada, Market Share of Major Players (%), 2020
  • Figure 32: Hospital Supplies Market, Canada, Revenue ($B), 2017-2025
  • Figure 33: Hospital Supplies Market, Canada, Market Share of Major Players (%), 2020
  • Figure 34: Cardiovascular Devices Market, Canada, Revenue ($B), 2017-2025
  • Figure 35: Cardiovascular Devices Market, Canada, Market Share of Major Players (%), 2020
  • Figure 36: Diabetes Care Devices Market, Canada, Revenue ($B), 2017-2025
  • Figure 37: Diabetes Care Devices Market, Canada, Market Share of Major Players (%), 2020
  • Figure 38: Diagnostics Market, Canada, Revenue ($B), 2015-2020
  • Figure 39: Diagnostics Market, Canada, Revenue Forecast ($B), 2021-2025
  • Figure 40: Medical Devices Market, Revenue ($B) of Major Companies, Canada, 2020
  • Figure 41: Deal Value and Deal Count, Pharmaceutical Market, Canada, 2020-2021
  • Figure 42: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Canada, 2020-2021
  • Figure 43: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Canada, 2020-2021
  • Figure 44: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Canada, 2020-2021
  • Figure 45: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Canada, 2020-2021
  • Figure 46: M&A Deals by Quarter, Pharmaceutical Market, Canada, 2020-2021 (by Value and by Number)
  • Figure 47: VC Deals by Quarter, Pharmaceutical Market, Canada, 2020-2021 (by Value and by Number)
  • Figure 48: Deal Value and Deal Count, Medical Devices Market, Canada, 2020-2021
  • Figure 49: Deal Value and Deal Count Sub-types, Medical Devices Market, Canada, 2020-2021
  • Figure 50: Deal Value and Deal Count, Quarterly, Medical Devices Market, Canada, 2020-2021
  • Figure 51: Top Equipment Areas by Deal Value ($B), Medical Devices Market, Canada, 2020-2021
  • Figure 52: Top Equipment Areas by Deal Count, Medical Devices Market, Canada, 2020-2021
  • Figure 53: M&A Deals by Quarter, Medical Devices Market, Canada, 2020-2021 (by Value and by Number)
  • Figure 54: VC Deals by Quarter, Medical Devices Market, Canada, 2020-2021 (by Value and by Number)
  • Figure 55: Key Areas of Focus, Digital Technology Supercluster, Canada, 2020
  • Figure 56: Top Digital Innovations, Canada, 2021
  • Figure 57: Objectives of Pan-Canadian AI Strategy, 2017
  • Figure 58: Deal Value ($M), HealthTech, Canada, 2020-2021
  • Figure 59: Deal Count (No. of Deals), HealthTech, Canada, 2020-2021
  • Figure 60: Adoption of Technology in Healthcare, Canada
  • Figure 61: Principles of Digital Charter Implementation Act, Canada, 2020
  • Figure 62: Organization of the Health System, Canada, 2020
  • Figure 63: Canadian Health Databases Managed by CIHI, Canada, 2021
  • Figure 64: Common Drug Review Process, Canada, 2020
  • Figure 65: Pan-Canadian Oncology Drug Review Process, Canada, 2020
  • Figure 66: INESSS Evaluation Process For Registration, Canada, 2020
  • Figure 67: Drug Reimbursement Process, Canada, 2020
  • Figure 68: Medical Devices Reimbursement Process, Canada, 2020
  • Figure 69: Private Insurance Coverage, Canada, 2013-2020
  • Figure 70: OOP Expenditure (% of Total Expenditure on Health), Canada, 2013-2020
  • Figure 71: Annual Rate of Change (%), Consumer Price Index, Healthcare Products (Base Year 2002=100), Canada, 2013-2020
  • Figure 72: HPFB Organizational Structure, Canada, 2019
  • Figure 73: CTD Format, Canada, 2020
  • Figure 74: New Drug Approval Process, Canada, 2020
  • Figure 75: New Medical Device Approval Process, Canada, 2021
  • Figure 76: Patent Registration Process, Canada, 2021
  • Figure 77: Trademark Registration Process, Canada, 2021
  • Figure 78: Clinical Trial Regulation Process, Canada, 2021
  • Figure 79: Pharmaceutical Clinical Trials Count by Trial Status, Canada, 2020-2021
  • Figure 80: Pharmaceutical Clinical Trials Count by Therapy Areas, Canada, 2020-2021
  • Figure 81: Pharmaceutical Clinical Trials Count by Phase, Canada, 2020-2021
  • Figure 82: Top Five Pharmaceutical Clinical Trial Sponsors by Count, Canada, 2020-2021
  • Figure 83: Medical Devices Clinical Trials Count by Trial Status, Canada, 2020-2021
  • Figure 84: Medical Devices Clinical Trials Count by Indication, Canada, 2020-2021
  • Figure 85: Medical Devices Clinical Trials Count by Category, Canada, 2020-2021
  • Figure 86: Top Five Medical Devices Clinical Trial Sponsors by Count, Canada, 2020-2021
  • Figure 87: PAAB Approval Process, Canada, 2021
  • Figure 88: Digital Health Canada Strategy 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!